Clicky

ENDRA Life Sciences Inc.(NDRA) News

Date Title
Aug 28 ENDRA Life Sciences Granted Extension to Regain Compliance with Nasdaq Continued Listing Requirements
Aug 7 ENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14
May 7 ENDRA Life Sciences to Report First Quarter 2024 Financial Results on May 14, 2024
May 2 ENDRA Life Sciences Strengthens Intellectual Property with Issuance of Five New International Patents
Nov 29 ENDRA Life Sciences Secures 39th U.S. Patent for TAEUS® System Technology
Nov 27 ENDRA Life Sciences to Participate in The Benchmark Company’s 12th Annual Discovery One-on-One Investor Conference
Nov 14 ENDRA Life Sciences Reports Third Quarter 2023 Financial Results and Provides Business Update
Nov 8 ENDRA Life Sciences Achieves Intellectual Property Milestone with Issuance of Three New Patents
Nov 7 ENDRA Life Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
Nov 6 ENDRA to Host Multidisciplinary Clinical Discussion on Managing Liver Disease During AASLD’s The Liver Meeting® 2023
Aug 23 ENDRA Life Sciences Expands Intellectual Property with Issuance of U.S. and European Patents
Aug 20 ENDRA Life Sciences Inc. (NASDAQ:NDRA) Q2 2023 Earnings Call Transcript